"FAK inhibitor-based combinations with MEK or PKC inhibitors trigger synergistic antitumor effects in uveal melanoma von Tarin, M., Némati, F., Decaudin, D., Canbezdi, C., Marande, B., Silva, L., Derrien, H., Jochemsen, A.G., Gardrat, S., Piperno-Neumann, S., Rodrigues, M., Mariani, P., Cassoux, N., Stern, M.H., Roman-Roman, S., Alsafadi, S.

Volltext bestellen